Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Gullestad

Showing results (41-50 of 382) with videos related to

Pageof 39
Sort By:
American Journal of Physical Medicine & Rehabilitation|July 19, 2011
Chronotropic responses to exercise in heart transplant recipients: 1-yr follow-upKari Nytrøen, Jonathan Myers, Khin Nyein Chan, et al.
Biomedicine Hub|August 11, 2020
β-Blocker Doses and Heart Rate in Patients with Heart Failure: Results from the National Norwegian Heart Failure RegistryTorfinn Eriksen-Volnes, Arne Westheim, Lars Gullestad, et al.
Journal of Cardiopulmonary Rehabilitation|April 2, 2003
Physical activity patterns and exercise performance in cardiac transplant recipientsJonathan Myers, Lars Gullestad, Daniel Bellin, et al.
Journal of the American College of Cardiology|August 6, 2021
Reply: Clarification Regarding the Lack of Heart Failure Events in the ASSAIL-MI TrialKaspar Broch, Anne Kristine Anstensrud, Sindre Woxholt, et al.
Heart Failure Reviews|March 9, 2018
The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventionsAnne Pernille Ofstad, Dan Atar, Lars Gullestad, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 23, 2018
Myocardial fibrosisTorvald Espeland, Ida Gjervold Lunde, Brage H Amundsen, et al.
Scandinavian Journal of Public Health|February 10, 2017
Reproducibility of an extensive self-report questionnaire used in secondary coronary preventionKari Peersen, John Munkhaugen, Lars Gullestad, et al.
Expert Opinion on Investigational Drugs|June 2, 2005
Agents targeting inflammation in heart failureLars Gullestad, John Kjekshus, Jan Kristian Damås, et al.
Scientific Reports|October 30, 2020
Distinct patterns of soluble leukocyte activation markers are associated with etiology and outcomes in precapillary pulmonary hypertensionTove Lekva, Lars Gullestad, Kaspar Broch, et al.
Clinical Transplantation|November 22, 2015
Peak oxygen uptake and self-reported physical health are strong predictors of long-term survival after heart transplantationMarianne Yardley, Odd E Havik, Ingelin Grov, et al.
Pageof 39

Showing results (41-50 of 382) with videos related to

Sort By:
Pageof 39
American Journal of Physical Medicine & Rehabilitation|July 19, 2011
Chronotropic responses to exercise in heart transplant recipients: 1-yr follow-upKari Nytrøen, Jonathan Myers, Khin Nyein Chan, et al.
Biomedicine Hub|August 11, 2020
β-Blocker Doses and Heart Rate in Patients with Heart Failure: Results from the National Norwegian Heart Failure RegistryTorfinn Eriksen-Volnes, Arne Westheim, Lars Gullestad, et al.
Journal of Cardiopulmonary Rehabilitation|April 2, 2003
Physical activity patterns and exercise performance in cardiac transplant recipientsJonathan Myers, Lars Gullestad, Daniel Bellin, et al.
Journal of the American College of Cardiology|August 6, 2021
Reply: Clarification Regarding the Lack of Heart Failure Events in the ASSAIL-MI TrialKaspar Broch, Anne Kristine Anstensrud, Sindre Woxholt, et al.
Heart Failure Reviews|March 9, 2018
The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventionsAnne Pernille Ofstad, Dan Atar, Lars Gullestad, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 23, 2018
Myocardial fibrosisTorvald Espeland, Ida Gjervold Lunde, Brage H Amundsen, et al.
Scandinavian Journal of Public Health|February 10, 2017
Reproducibility of an extensive self-report questionnaire used in secondary coronary preventionKari Peersen, John Munkhaugen, Lars Gullestad, et al.
Expert Opinion on Investigational Drugs|June 2, 2005
Agents targeting inflammation in heart failureLars Gullestad, John Kjekshus, Jan Kristian Damås, et al.
Scientific Reports|October 30, 2020
Distinct patterns of soluble leukocyte activation markers are associated with etiology and outcomes in precapillary pulmonary hypertensionTove Lekva, Lars Gullestad, Kaspar Broch, et al.
Clinical Transplantation|November 22, 2015
Peak oxygen uptake and self-reported physical health are strong predictors of long-term survival after heart transplantationMarianne Yardley, Odd E Havik, Ingelin Grov, et al.
Pageof 39